Molecular Physiology And Biophysics

The Vanderbilt University School of Medicine Basic Sciences has named eight Ph.D. students as recipients of the 2026 Dean’s Award for Exceptional Achievement in Graduate Studies, recognizing their outstanding research accomplishments and excellence in graduate education. Read More

Eating breakfast affects how our livers respond to lunch. Research from the Department of Molecular Physiology and Biophysics indicates that this well-known, metabolic memory phenomenon is a result of hormonal interplay and points to critical roles not just for insulin but for glucagon as well. Read More

Celebrate the 10-year anniversary of the School of Medicine Basic Sciences by recognizing 10 of our hundreds of exemplary alums who have completed their training in the School of Medicine Basic Sciences Read More

Congratulations to our School of Medicine Basic Sciences faculty members who were promoted or received new appointments between January and March 2026! These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More

Celebrate the 10-year anniversary of the School of Medicine Basic Sciences by revisiting 10 scientific discoveries and achievements from our short history. Read More

In honor of the 2026 Women’s History Month, the Vanderbilt University School of Medicine Basic Sciences is highlighting female faculty from our school. We asked them to reflect on their journeys and the changes they have experienced in how biomedical research and academia treat their women. Read More

Dr. Teru Nakagawa delivered the inaugural Kairos Lecture. Read More

Dr. Teru Nakagawa, professor of molecular physiology and biophysics in the School of Medicine Basic Sciences, will deliver the inaugural Kairos Lecture on Thursday, Feb. 26, 2026. Read More

The School of Medicine Basic Sciences is launching a new lecture series: “The Kairos Lectures: Research of Consequence at the Right Moment.” Read More

In a new study published in Diabetes, researchers found that prolonged treatment with the GLP-1R agonist semaglutide led to changes in feeding habits and fuel use in an animal model, offering new insights into the behavioral and metabolic adaptations that accompany weight loss, weight maintenance, and rapid weight regain after stopping treatment. Read More